Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000005

Chief Medical Officer sold 49,638 shares at an average $50.08 ($2,485,989)

  • Chief Medical Officer acquired 43,973 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-04 Exercise or conversion : show line 1 in the form +8,526 $35.16 $299,774 15,841 D
2020-02-04 Sale : show line 2 in the form −14,191 $50.03 $709,963 1,650 D
2020-02-05 Exercise or conversion : show line 3 in the form +35,447 $35.16 $1,246,317 37,097 D
2020-02-04 Sale : show line 4 in the form −35,447 $50.10 $1,776,026 1,650 D
Open-market sales · 49,638 sh · avg $50.08 · $2,485,989

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-02-04 Exercise or conversion : show line 5 in the form Stock option (right to buy) −8,526 62,474 D
2020-02-05 Exercise or conversion : show line 6 in the form Stock option (right to buy) −35,447 27,027 D
Loading xslF345X03/wf-form4_158102593034853.xml…